Send feedback

EPAS1 p.His231=

c.693C>T · rs1299764337 · VCV1756241

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)
Conditions
1
Inborn genetic diseases

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.41GERP -1.1, phastCons 0.99
Overall
CADD7.332PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,084 alleles
Filtering AF 0.00175% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00104%
Overall 0.000496% 8/1,614,066 alleles · ultra-rare
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.0164% 6,084
African / African-American 0.00534% 18,728
Remaining individualsnot grpmax-eligible 0.0032% 31,243
European (non-Finnish) 8.47e-05% 1,180,048

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
EPAS1
Protein
p.His231=
Coding
c.693C>T
MANE Select
NM_001430
dbSNP
rs1299764337
Type
single nucleotide variant
Location
chr2:46361004 (GRCh38)
Gene constraint
LOEUF 0.366 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 59.41 · 43 PDB
Residue 231
the pas 2 domain
Full EPAS1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/epas1-p-his231 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown